The Next Generation of Newborn Screening

New review explores how next-generation sequencing could enhance early disease detection in newborns

1

Next-generation sequencing (NGS) enhances traditional newborn screening by identifying serious genetic conditions that biochemical tests may miss.
2

Genomic newborn screening (gNBS) can detect disease-causing genetic variants, enabling earlier identification of inherited conditions.
3

Pilot programs show gNBS identifies actionable genetic diseases missed by standard screening, including immunodeficiencies and neuromuscular disorders.
4

Current gNBS initiatives focus on well-characterized conditions to minimize ambiguous results and reduce parental anxiety.
5

Advancements in rapid sequencing pipelines are reducing turnaround times, with results now available in about 7 days for critically ill infants.

1